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Abstract  
Introduction: Focus has been put on strengthening surveillance systems in high tuberculosis (TB) burden countries, like Zambia, however 
inadequate information on factors associated with unfavourable TB treatment outcomes is generated from the system. We determined the 
proportion of tuberculosis treatment outcomes and their associated factors. Methods: We defined unfavourable outcome as death, lost-to-follow-
up, treatment-failure, or not-evaluated and favourable outcome as a patient cured or completed-treatment. We purposively selected a 1st level 
hospital, an urban-clinic and a peri-urban clinic. We abstracted data from TB treatment registers at these three health facilities, for all TB cases on 
treatment from 1st January to 31st December, 2015. We calculated proportions of treatment outcomes and analysed associations between 
unfavourable outcome and factors such as age, HIV status, health facility, and patient type, using univariate logistics regression. We used 
multivariable stepwise logistic regression to control for confounding and reported the adjusted odds ratios (AOR) and 95% confidence intervals 
(CI). Results: We included a total of 1,724 registered TB patients, from one urban clinic 694 (40%), a 1st Level Hospital 654 (38%), and one peri-
urban-clinic 276 (22%). Of the total patients, 43% had unfavourable outcomes. Of the total unfavourable outcomes, were recorded as treatment-
failure (0.3%), lost-to-follow-up (5%), death (9%) and not evaluated (29%). The odds of unfavourable outcome were higher among patients > 59 
years (AOR=2.9, 95%CI: 1.44-5.79), relapses (AOR=1.65, 95%CI: 1.15-2.38), patients who sought treatment at the urban clinic (AOR=1.76, 
95%CI:1.27-2.42) and TB/HIV co-infected patients (AOR=1.56, 95%CI:1.11-2.19). Conclusion: Unfavourable TB treatment outcomes were high 
in the selected facilities. We recommend special attention to TB patients who are > 59 years old, TB relapses and TB / HIV co-infected. The 
national TB programme should strengthen close monitoring of health facilities in increasing efforts aimed at evaluating all the outcomes. Studies 
are required to identify and test interventions aimed at improving treatment outcomes. 
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Introduction 
 
Tuberculosis (TB) has continued to be one of the major public 
health problems and still remains a global emergency for the 
21st century [1]. Analysing TB treatment outcomes and their 
potential risk factors is an important indicator of the performance of 
a country's TB control program [2]. Monitoring and evaluation of TB 
patients’ treatment outcomes has been given priority in the End TB 
Strategy, as an integral part in the treatment and prevention of TB 
[3]. World Health Organisation (WHO) recommends a 90% TB 
treatment success rate, which can be achieved through intensified 
case finding, early diagnosis, availability of medicines, and direct 
observed therapy in a TB control programme [1]. The estimated TB 
incidence in 2015 was 391/100,000 population for all ages and 
treatment success rate of 85% was reported [4]. Many studies have 
been done looking at factors associated with unfavourable TB 
treatment outcomes. A retrospective cohort study done in Nigeria 
found that re-treatment cases, having a positive smear at the 
second month of follow-up, smear-negative after 2 months of 
treatment, pulmonary TB, and being male were associated with 
unfavourable TB treatment outcomes [5]. This study, however, only 
looked at TB in children. Another study in Mozambique found that 
being male, having a negative smear result at diagnosis, being HIV 
positive, and being a retreatment case was associated with 
unfavourable treatment outcomes [6]. A study conducted in Lusaka 
[7], found that socio-demographic factors including poverty, being a 
woman, having extra-pulmonary TB, old age, marital status, and 
HIV co-infection are associated with unfavourable treatment 
outcomes. 
  
The burden of TB in Zambia has continued to be high over the years 
despite the low TB case notification which could be attributed to 
high rates of undetected TB cases (42%), delayed diagnosis and 
low utilization of TB preventive therapy (18%) hence seeing 
unfavourable treatment outcomes above the WHO threshold of less 
than 5% [8]. Lusaka the capital city of Zambia has some residential 
areas that came up as a result of rural-urban migration. Apart from 
this Lusaka also has a number of industries and private businesses 
which in turn makes a destination centre for people looking for 
employment and petty trade. This could have led to the increase in 
the number of TB cases notified for the reason that these people 
are subjected to poor living conditions [7]. During 2015 a national 
total of 41588 TB cases was notified, of which 16339 (39%) were 
notified in Lusaka alone [9]. The afore-mentioned studies indicate 
that different factors have been associated with TB treatment 
outcomes in different countries, as well as in different communities 
within the same country. Therefore, information and identification of 
factors which affect treatment outcomes in different settings is 
important to understand contextual problems and accordingly 
design appropriate community/population-based strategies to 
reduce the disease burden. In Lusaka district, surveillance data is 
not routinely analysed to identify possible risk factors that 
negatively affect treatment outcomes. Therefore, we determined 
the proportion of factors associated with unfavourable TB treatment 
outcomes in selected facilities within Lusaka district for the period 





Definitions of TB treatment outcomes: Using the WHO 
definition [10], a TB case was defined as either (1) a 
bacteriologically confirmed biological specimen positive by either 
smear microscopy, culture, or Gene Xpert, or (2) clinically diagnosed 
with TB by a clinician or other medical practitioner who has decided 
to give the patient a full course of TB treatment. Unfavourable TB 
treatment outcomes were defined as: 
  
Death: A TB patient who died for any reason before starting or 
during the course of treatment. 
  
Lost-to-follow-up: A patient who did not start treatment or 
treatment interrupted for 2 consecutive months or more. 
  
Treatment failure: A patient with sputum smear or culture is 
positive at month 5 or later during treatment. 
  
Not evaluated:  Patient who has no treatment outcome reported 
in the TB treatment register. Thus, it is not clear if a "not evaluated" 
patient has been transferred out to another treatment unit, or if 
their treatment outcome is truly unknown. 
  
Favourable TB treatment outcomes include: 
  
Cure: A pulmonary TB patient with bacteriologically confirmed TB at 
the beginning of treatment who was smear- or culture-negative in 
the last month of treatment and on at least one previous occasion). 
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Treatment completion: A TB patient who completed treatment 
without evidence of failure BUT with no record to show that sputum 
smear or culture results in the last month of treatment and on at 
least one previous occasion were negative, either because tests 
were not done or because results are unavailable. 
  
We further defined: 
  
Urban clinic: TB treatment and diagnostic centre that exists in a 
properly planned area in the city. 
  
Peri-urban clinic: TB treatment and diagnostic centre which exists 
in an unplanned settlement due to rural urban migration. 
  
Data collection and variables: We abstracted variables from the 
TB treatment registers that were related to the study objectives. 
Patients' age, gender, health facility type, type of TB, treatment 
category, and HIV-status were the main explanatory variables. In 
addition to standard outcome definitions, we classified the final 
treatment outcome as a dichotomous variable, i.e., favourable 
outcome (cured or treatment completed) vs unfavourable outcome 
(death, loss to follow-up, failure or not evaluated) outcomes. We 
included patients with either bacteriologically confirmed or clinical 
diagnosed pulmonary tuberculosis (PTB), as well as extra pulmonary 
tuberculosis (EPTB) and excluded all patients transferred in from 
other facilities as well as drug resistant TB patients because these 
forms are reported separately from drug susceptible TB. 
  
Sampling and sample size: All the 23 TB diagnostic centres in 
Lusaka district were put into three categories: hospitals, urban 
clinics and peri-urban clinics. Based on the anecdotal data from the 
Ministry of Health, each of these facilities reported more than 300 
cases of TB in 2015. We therefore purposively sampled one 1st level 
Hospital, one urban-clinic and one peri-urban clinic. The sample size 
was estimated by using the following formula for survey sample 




Where n = the required sample size Z1-α/2 = value of the standard 
normal distribution (1.96) corresponding to a significance level of 
0.05 for a 2-sided test. d = margin of error (0.05) p = 0.5 based on 
the assumption that 50% of the population have unfavourable 
outcomes due to an unknown prevalence Sample size (n) = 384. 
Despite having a minimum sample size of 384, we did a complete 
review and abstraction of all records for confirmed TB cases on 
treatment during the year 2015 from the standard paper TB 
treatment registers and verified the recorded information with 
individual patient TB treatment cards. 
  
Data analysis methods: We entered abstracted data from paper-
based TB registers into an electronic MS Excel 2010 data entry form 
and exported to Stata Version 13 analysis software for cleaning and 
analysis. A histogram was used to graphically check for normality 
(graphs not shown). The continuous variable age which was 
normally distributed was categorised to see the various effects in 
different age categories. Categorical data such as sex was reported 
using numbers and percentages, chi-square test was used to 
ascertain associations with unfavourable outcomes. Odds ratios 
were reported as a measure of association for categorical variables 
using logistic regression. The proportions were calculated using the 
number of cases recorded per type of outcome (that is favourable 
and unfavourable outcome from 1st January to 31st December 2015) 
data abstracted as the numerator and using the total TB confirmed 
cases as denominator. Univariate and multivariable logistic 
regression was performed, the outcome variable was whether or not 
the individual had unfavourable outcome (treatment failure, died, 
not evaluated or lost to follow up) or not in 2015. Risk factors 
assessed include age, sex, location of health facility, HIV status, 
type of TB, patient type (new, relapse, transfer in or treatment 
resume case). For the logistic regressions performed using alpha = 
0.05, odds ratios and corresponding 95% confidence intervals were 
calculated for the various risk factors. To keep some priori variables 
in the model for the multivariable logistic regression, we performed 
a backward stepwise logistic regression. We subtracted variables 
from the model using the influence of literature review. Selection of 
the best model was guided by the likelihood ratio test, Akaike 
Information Criteria and Bayesian Information Criteria after 
estimation of the nested models by eliminating variables one at a 
time. To further understand the treatment outcomes, we performed 
a multivariable analysis by excluding the not evaluated category 
from the unfavourable outcomes because, by definition, the real 
outcome of the patients was unknown. Ethical clearance was 
obtained from Excellence in Research Ethics and Science (ERES) 
Ethics Committee (Ref: 2017-June-013), and permission to conduct 
a study was obtained from the Zambia Ministry of Health. 
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Results 
 
Socio-demographic characteristics and outcome of 
patients: We included a total of 1,724 registered TB patients, from 
the urban clinic 694 (40%), 1st Level Hospital 654 (38%) and peri-
urban-clinic 276 (22%) (Table 1). The majority of TB patients were 
males 1,128 (65.4%), and the age ranged from 0 to 91 years with 
the majority of patients (51%) aged 30 to 44 years and 985 (57%) 
had favourable outcomes. Among those with favourable outcomes, 
307(18%) were cured and 678 (39%) had completed treatment. 
The overall treatment success rate for the three health facilities was 
57%. We found that 506 (29%) patients were not evaluated, 138 
(8%) died, 90 (5%) were lost to follow up and 5 (0.3%) had 
treatment failure giving an unfavourable outcome of 43%. 
  
Association between demographic/clinical characteristics 
and treatment outcome among TB patients in Lusaka, 
Zambia, 2015: Univariate logistic regression analysis (Table 2) 
revealed that TB patients above 59 years old had higher odds 
(unadjusted odds ratio (OR) = 1.65, 95% CI: 1.02, 2.68, p = 0.04) 
of having unfavourable outcomes compared to those aged 45-59 
years, relapse patients had increased odds of unfavourable 
outcomes (OR = 1.55, 95% CI: 1.22-1.97, p = < 0.001) compared 
to new patients. Patients who sought treatment at the urban-clinic 
(OR = 1.7, 95% CI: 1.36-2.14, p = < 0.001) and peri-urban-clinic 
(OR = 4.1, 95% CI: 3.13-5.36, p = <0.001) were more likely to 
develop unfavourable outcomes compared to those who sought 
treatment at the 1st Level referral hospital. Male TB patients were 
more likely (OR = 1.24, 95% CI: 1.02-1.52, p = 0.03) to develop 
unfavourable outcomes compared to female TB patients. HIV co-
infected TB patients had a statistically significant increased chance 
of developing unfavourable outcomes compared to HIV negative TB 
patients (OR = 1.22, 95% CI: 1.00-1.51, p = 0.05). 
  
Analysis of factors associated with Treatment Outcome 
among TB Patients in Lusaka, Zambia, 2015: The multivariable 
logistic regression (Table 3) showed that the odds of unfavourable 
outcome was significantly higher among relapse patients (aOR = 
1.8, 95% CI: 1.42-2.26, p = < 0.001) compared to new patients 
after adjusting for patient type, location of health facility, age-
group, and HIV status. Patients who sought treatment at the urban-
clinic (aOR = 1.8, 95% CI: 1.42-2.26, p = <0.001) and peri-urban-
clinic (aOR = 4.3, 95% CI: 3.22-5.66, p = <0.001) were more likely 
to develop unfavourable outcomes compared to the 1stLevel referral 
hospital after adjusting for all other factors. The odds (aOR = 1.05, 
95% CI: 0.84-1.30, p = 0.67) of unfavourable outcomes were 
higher among HIV-TB coinfected patients compared to HIV negative 
TB patients after adjusting for all other factors, the association was 
however not statistically significant. TB patients aged above 59 
years old had higher odds (aOR = 1.8, 95% CI: 1.09, 3.10, p = 
0.02) of developing TB compared to those age 45-59 years after 
adjusting for all other factors. When we excluded the not evaluated 
category (Table 3) in the multivariable logistic regression we noticed 
that the odds (aOR = 1.56, 95% CI: 1.11-2.19, p = 0.01) of 
unfavourable outcomes was significantly higher among the HIV-TB 
co-infected patients compared to those HIV negative TB patients 





The present study has highlighted factors associated with 
unfavourable tuberculosis treatment outcomes among selected 
health facilities in Lusaka, Zambia, 2015. The study has shown that 
TB patients that were relapse, HIV co-infected, above 59 years old 
and those who sought treatment from the urban clinic had 
increased odds of unfavourable outcomes. The WHO has set 
standards for reporting of outcome of anti-tuberculosis treatment 
[10]. Treatment outcomes are a major indicator in the assessment 
of performance of a national TB programme [1]. In this study, most 
of the TB patients were males which is similar to findings from other 
studies [11, 12]. One suggested reason for a higher proportion of 
males having unfavourable outcomes is that they may be more 
exposed to TB infections associated with behavioural factors such as 
ex: smoker, as compared to women [13, 14]. Another possible 
explanation is that males and females have different societal roles 
and occupations (such as working in a mine) that can influence not 
only their risk of exposure to TB but also their access to care 
[12, 15]. A qualitative study done in Burundi found women to have 
good patient and self-care in their families which made them more 
compliant to TB treatment compared to males hence the seen 
differences [16]. This finding can also be used to explain our 
findings in this study the difference in study design. 
  
This study found an overall treatment success rate of 57% for the 
three facilities sampled, and this was lower than the 86% reported 
for the entire Lusaka district. This finding may mean that overall 
figures reported in Lusaka district are likely to mask lower treatment 
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success levels in health facilities not performing well. It also 
suggests that achieving the treatment success target for some 
health facilities is a major challenge that needs to be tackled. The 
overall unfavourable TB treatment outcome rate was higher than 
the unfavourable treatment outcome reported from Ethiopia 
[2, 17, 18]. This result is also higher than another study conducted 
in Malaysia which reported a rate of 21.5% [19]. High rates of 
missing TB cases which stand at 42% and low utilization of TB 
preventive therapy current at 18% could be contributing to the 
unfavourable outcome seen in the study [8]. The findings of this 
study show a high number of cases not evaluated which shows that 
there is poor record keeping in the three health facilities. The high 
unfavourable treatment outcome found in this study affects the 
country's overall goal of achieving the 90% treatment success rate 
as recommended by the WHO hence there is need to conduct data 
quality audits to health facilities in order to addressing the 
challenges faced in data management. Many studies have shown 
similar to this study that old age is associated with unfavourable 
outcome in TB treatment [2, 19]. This finding could be attributed to 
an increased risk of lower immunity, making them more susceptible 
to infections, as a person grows older which may lead to poor 
outcomes [2, 20]. One important limitation is that secondary TB 
register data was used for this study, so we could not control for the 
age-associated co-morbidities. Findings of a study in Ethiopia [21] 
are different from what this study found this could be due 
differences in geographical location also possible confounders due 
to use of secondary data. 
  
This study also showed that relapse patients had higher odds of 
developing unfavourable outcomes compared to new cases. Similar 
to this, a study in India found that relapse cases had a higher risk of 
developing unfavourable outcomes compared to new cases [22]. 
This result could be due to many factors, including lack of 
adherence, higher rates of lost to follow up and higher drug 
resistance rates among relapse patients [6]. This association could 
not be shown in this study, because we used secondary data which 
did not capture these variables. A study conducted in Nigeria did not 
find any associations between new and relapse patients [23]. In this 
study, the health facility where a patient was receiving care from 
was found to be associated with unfavourable outcome. This is 
similar to a findings from a study done in northern Ethiopia where 
they compared treatment outcomes from different health facilities 
[24]. This finding could be as a result of different levels of care 
received at the facilities. This may include availability of TB 
diagnostic tools such as Gene-Xpert machines that makes diagnosis 
easy and fast compared to use of microscopes or culture. It may 
also be a behavioural factor that could be common in one 
geographical area of the district, leading to unfavourable treatment 
outcomes [25, 26]. This is an area that calls for future research to 
see what risk factors exist in different locations that may put people 
at higher risk of unfavourable outcomes in the TB treatment. 
Different from this study, in Nigeria a study compared rural against 
urban facility and their finding was that patients in rural areas were 
more associated with unfavourable outcomes [23]. This information 
tells us there is need to monitor health facilities to learn practices 
from those that are doing well and trickle them down to those that 
are not performing well. 
  
The multivariable analysis conducted revealed that after removing 
the not evaluated category whose outcomes were unknown; HIV 
positive TB patients were more likely to develop unfavourable 
outcomes. Similar to other studies [27, 28] our study found HIV 
positive TB patients to be associated with unfavourable outcome. 
HIV is known to affect the immune system of individuals making 
them more susceptible to opportunistic infections such as TB [29]. It 
has been suggested that HIV positive TB patients are more likely to 
become malnourished due to constant sickness, have diarrhoea that 
prevents absorption of nutrients, loss of appetite and sores of 
mouth that make eating difficult, and also experience more 
opportunistic infections [14, 23]. Another reason for unfavourable 
outcomes among HIV positive TB patients could be poor uptake of 
anti-retro viral therapy (ART) [28, 30]. This study however did not 
analyse the association between ART and unfavourable treatment 
outcomes among HIV positive TB patients due to missing 
information from the registers. This therefore calls for improved 
action in ensuring that health facilities record and report all TB 
treatment outcomes. Failure to do so may lead to missing of very 
important information required for effective service delivery in the 
diagnosis and treatment of TB. The study was a review of data 
records in the sampled three health facilities. Socio demographic 
information such as drinking habits, education levels, marital status 
and employment [7,24] were not available. Any bias introduced by 
lack of availability of this data, may have underestimated the 
association between potential risk factors and treatment outcomes; 
availability of missing information would have strengthened the 
association between risk factors and treatment outcomes. Our study 
purposively sampled three health facilities in Lusaka district. Also 
the fact that the selection was purposive possible bias might have 
been introduced which have over or underestimated the true 
magnitude of the relationship between the exposure and an 
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outcome. This may affect the generalizability of results obtained to 
the Lusaka district. However, this study was able to identify the 
potential risk factors associated with unfavourable outcome in the 
treatment of TB and sampled all the three different categories of TB 
diagnostic health facilities in Lusaka. These findings may help the 
national TB programme to adopt effective strategies in the 





This study has found a high proportion of unfavourable outcomes in 
three health facilities in Lusaka, which was associated with being > 
59 years old, being a relapse case, being HIV positive and receiving 
care from the urban-clinic. We recommend special attention to 
patients of > 59 years old, relapse cases and HIV positive receiving 
TB treatment and also close supervision and monitoring of health 
facility staff, an effort aimed at evaluating outcomes of notified 
patients. Studies are required to identify and test interventions 
aimed at improving treatment outcomes at all levels of health care. 
 
What is known about this topic 
 Unfavourable TB treatment outcomes are associated with 
being > 59years old, being a relapse case; 
 HIV co-infected TB patients are association with 
unfavourable treatment outcomes. 
What this study adds 
 Using routine surveillance data unfavourable outcome are 
more likely to occur at an urban clinic compared to a 
1st level hospital; 











Francis Hamaimbo Nanzaluka, Sylvia Chibuye, Nelia Langa designed 
the study, performed the statistical analyses and data interpretation, 
and wrote the manuscript. Sulani Nyimbili, Clara Chola Kasapo, 
Given Moonga contributed to interpretation of data and manuscript 
revisions. Ramya Kumar, Gershom Chongwe, Nathan Kapata 
contributed to study design and analyses and supervised this study. 





Financial support was obtained in part from U.S. President's 
Emergency Plan for AIDS Relief (PEPFAR). We thank Dr Rhehab 
Chimzizi, Dr Sylvia Chila and Dr Ellen Yard for their mentorship and 
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Table 1: Socio-demographic characteristics and treatment outcomes of the registered TB Cases  (N = 1724) at three health 








Total n(%) P-Value 
TOTAL (n) 694 654 376 1724 <0.001 a 
Sex         
0.57a Male 445 (64) 430 (66) 253 (67) 1128 (65) 
Females 249 (36) 224 (34) 123 (33) 596 (35) 
Age group 
    
0.17a 
0-14 33 (4) 37 (5) 7 (2) 77 (4) 
15-29 174 (25) 162 (25) 110 (29) 446 (26) 
30-44 358 (52) 324 (50) 192 (51) 874 (51) 
45-59 94 (14) 91 (14) 48 (13) 233 (14) 
> 59 35 (5) 40 (6) 18 (5) 93 (5) 
OUTCOME 
    
<0.001a 
Favourable 
    
Cured 186 (27) 87 (13) 34 (9) 307 (18) 
Treatment Complete 210 (30) 368 (56) 100 (27) 678 (39) 
Favourable outcome 
[Treatment success rate 
(%)] 
396 (57) 455 (70) 134 (36) 985 (57) <0.001a 
Unfavourable 
    
<0.001a 
Not evaluated 173 (25) 117(18) 216 (57) 506 (29) 
Died 51 (7) 67 (10) 20 (5) 138 (8) 
Lost To Follow Up 74 (11) 10 (2) 6 (2) 90 (5) 
Failure 0 (0) 5 (0.3) 0 (0) 5 (0.3) 
Unfavourable outcome 
(%) 
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Table 2: Association between demographic /clinical characteristics and  treatment outcome among TB patients in 
Lusaka, Zambia, 2015 






UOR (95% CI) P-Value 
Sex 
    
Female 361 (61) 235 (39) 1.00 
 
Male 623 (55) 505 (45) 1.24 (1.02, 1.52) 0.03 
Age group 
    
45-59 144 (62) 89 (38) 1.00 
 
0-14 52 (68) 25 (32) 0.78 (0.45, 1.34) 0.40 
15-29 258 (58) 188 (42) 1.17 (0.85, 1.63) 0.32 
30-44 484 (55) 390 (45) 1.3 (0.96, 1.75) 0.08 
>59 46 (49) 47 (51) 1.65 (1.02, 2.68) 0.04 
Patient Type 
    
New 799 (60) 542 (40) 1.00 
 
Relapse 166 (49) 175 (51) 1.55 (1.22, 1.97) <0.001 
Treatment Resume 16 (44) 20 (56) 1.84 (0.95, 3.59) 0.07 
TB Type 
    
Extra Pulmonary 161 (57) 120 (43) 1.00 
 
Pulmonary 821 (57) 618 (43) 1.00 (0.78, 1.31) 0.94 
HIV Status 
    
Negative 351(61) 224 (39) 1.00 
 
Positive 617 (57) 483 (43) 1.22 (1.0, 1.51) 0.05 
Health Facility 
    
1st Level Hospital 356(54) 298 (43) 1.00 
 
Urban-Clinic 494 (71) 200 (31) 1.7 (1.36, 2.14) <0.001 
Peri-Urban-Clinic 134 (36) 242 (64) 4.1 (3.13, 5.36) <0.001 
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Table 3: Analysis of factors associated with treatment outcome among TB patients in Lusaka, Zambia, 2015 
Characteristic AOR (95% CI) P-Value 
AOR (95% CI) excluding 
not evaluated category 
P-Value 
Age group     
  
45-59 1.00   1.00 
 
0-14 1.11 (0.62, 1.96) 0.73 1.17 (0.50, 2.70) 0.72 
15-29 1.2 (0.85, 1.72) 0.28 1.30 (0.77, 2.19) 0.32 
30-44 1.4 (0.99, 1.86) 0.06 1.37 (0.80, 2.04) 0.3 
>59 1.8 (1.09, 3.10) 0.02 2.90 (1.44, 5.79) 0.003 
Patient Type     
  
New 1.00   
  
Relapse 1.8 (1.42, 2.26) <0.001 1.65 (1.15, 2.38) 0.007 
Treatment Resume 1.5 (0.71, 3.01) 0.31 2.20 (0.88, 5.54) 0.093 
Health Facility     
  
1st level hospital 1.00   1.00 
 
Urban-Clinic 1.8 (1.42, 2.26) <0.001 1.76 (1.27, 2.42) 0.001 
Peri-Urban-Clinic 4.3 (3.22, 5.66) <0.001 1.05 (0.64, 1.74) 0.834 
HIV Status     
  
Negative 1.00   1.00 
 
Positive 1.06 (0.85, 1.32) 0.62 1.56 (1.11, 2.19) 0.01 
CI; Confidence interval; aOR, Adjusted Odds ratio 
  
 
